To exclude the influence of clinical features other than ER status on the results, we further analyzed and compared the clinical differences between ER positive, ER negative breast cancer patients and healthy controls (Supplementary Table 3), and we found that age, family history and HER-2 expression were not correlated with ER. This evidence concerns the gene ERBB2 and breast cancer.